Andres Y. Maldonado

Andres Y. Maldonado Ph.D. has held several positions in the field of biotechnology. Andres Y. started working as an Equity Research Associate at Cowen and Company in 2018, where they focused on analyzing biotechnology companies. In 2020, they joined H.C. Wainwright & Co., LLC as a Vice President in the Biotechnology division. Their roles in both companies demonstrate their expertise and experience in the biotechnology industry.

Andres Y. Maldonado Ph.D. began their education at the University at Albany, SUNY, where they completed their Bachelor of Science (B.S.) degree in Chemistry from 2003 to 2007. Andres Y. then pursued a Master of Science (M.S.) degree in Chemistry at the same institution from 2007 to 2008.

Continuing their academic journey, Maldonado went on to earn their Doctor of Philosophy (Ph.D.) in Biochemistry and Biophysics from the University at Albany, SUNY, where they studied from 2009 to 2012.

Following the completion of their Ph.D., Maldonado became a Post-Doctoral Fellow at the Icahn School of Medicine at Mount Sinai. Andres Y. conducted research at The Tisch Cancer Institute from 2013 to 2018, furthering their knowledge and expertise in the field.

In addition to their educational achievements, Maldonado has obtained several certifications from the Financial Industry Regulatory Authority (FINRA). These include the Securities Industry Essentials Examination (SIE), the Series 86 - Research Analyst (Part I), and the Series 87 - Research Analyst (Part II). The specific months and years of when they obtained these certifications are not provided.